Pacitti David C.'s most recent trade in Orchestra BioMed Holdings Inc was a trade of 21,277 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 21,277 | 21,277 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 17,327 | 62,295 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Jun 2026 | 3,784 | 58,511 | - | 0 | Common Stock | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.53 per share. | 14 Apr 2026 | 21,194 | 322,194 (0%) | 0% | 14.5 | 307,949 | Common Stock |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 241,021 | 241,021 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 239,354 | 239,354 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 239,354 | 239,354 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 101,341 | 343,388 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 101,341 | 343,388 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | David C. Pacitti | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 101,341 | 343,388 (0%) | 0% | 0 | Common Stock | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 15,000 | 44,968 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 36,797 | 36,797 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 12,422 | 29,968 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 17,068 | 17,068 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | David C. Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 5,376 | 17,546 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | C. David Pacitti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 34,633 | 34,633 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Pacitti David C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 10,000 | 12,170 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |